D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+6.26%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$86.9B
AUM Growth
+$5.39B
Cap. Flow
-$9.66B
Cap. Flow %
-11.11%
Top 10 Hldgs %
12.61%
Holding
3,953
New
911
Increased
1,029
Reduced
1,305
Closed
355

Top Buys

1
QCOM icon
Qualcomm
QCOM
+$555M
2
MPC icon
Marathon Petroleum
MPC
+$538M
3
F icon
Ford
F
+$529M
4
WMT icon
Walmart
WMT
+$508M
5
AAPL icon
Apple
AAPL
+$499M

Sector Composition

1 Technology 20.88%
2 Consumer Discretionary 13.12%
3 Healthcare 9.93%
4 Communication Services 9.58%
5 Financials 7.83%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DGNR.WS
3201
DELISTED
Dragoneer Growth Opportunities Corp. Redeemable warrants, each whole warrant exercisable for one Cla
DGNR.WS
$80K ﹤0.01%
40,000
GAU
3202
Galiano Gold
GAU
$615M
$79K ﹤0.01%
72,458
+48,803
+206% +$53.2K
KLDO
3203
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$78K ﹤0.01%
+10,483
New +$78K
ASXC
3204
DELISTED
Asensus Surgical, Inc.
ASXC
$77K ﹤0.01%
+24,232
New +$77K
SCAQW
3205
DELISTED
Stratim Cloud Acquisition Corp. Warrant
SCAQW
$77K ﹤0.01%
+92,261
New +$77K
ATHN.WS
3206
DELISTED
Athena Technology Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one shar
ATHN.WS
$77K ﹤0.01%
+88,888
New +$77K
FOA icon
3207
Finance of America Companies
FOA
$284M
$76K ﹤0.01%
+1,000
New +$76K
SMMT icon
3208
Summit Therapeutics
SMMT
$13.1B
$76K ﹤0.01%
+10,162
New +$76K
APGB.WS
3209
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
$76K ﹤0.01%
+60,000
New +$76K
TRCA.WS
3210
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$76K ﹤0.01%
+83,333
New +$76K
OTLK icon
3211
Outlook Therapeutics
OTLK
$44.4M
$75K ﹤0.01%
+1,507
New +$75K
NBSTW
3212
DELISTED
Newbury Street Acquisition Corporation Warrants
NBSTW
$74K ﹤0.01%
+100,000
New +$74K
NBEV
3213
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$73K ﹤0.01%
+32,519
New +$73K
CMCM
3214
Cheetah Mobile
CMCM
$226M
$72K ﹤0.01%
6,060
-12,803
-68% -$152K
LCTX icon
3215
Lineage Cell Therapeutics
LCTX
$276M
$72K ﹤0.01%
+25,219
New +$72K
FVT.WS
3216
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$71K ﹤0.01%
59,415
GSMGW
3217
DELISTED
Cheer Holding, Inc. Warrant expiring 2/13/2025
GSMGW
$70K ﹤0.01%
498,473
-2,300
-0.5% -$323
SCOBW
3218
DELISTED
ScION Tech Growth II Warrants
SCOBW
$69K ﹤0.01%
+75,000
New +$69K
GNSS icon
3219
Genasys
GNSS
$94.8M
$67K ﹤0.01%
+12,301
New +$67K
LVRAW
3220
DELISTED
Levere Holdings Corp. Warrant
LVRAW
$67K ﹤0.01%
+66,666
New +$67K
PDOT.WS
3221
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$67K ﹤0.01%
+60,000
New +$67K
ASAXW
3222
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$67K ﹤0.01%
+100,000
New +$67K
GALT icon
3223
Galectin Therapeutics
GALT
$320M
$66K ﹤0.01%
20,607
-25,168
-55% -$80.6K
PHAS
3224
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$66K ﹤0.01%
+17,674
New +$66K
NWG icon
3225
NatWest
NWG
$57.6B
$65K ﹤0.01%
21,375